Overview

Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer

Status:
Unknown status
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
Post operative adjuvant chemotherapy followed by adjuvant Tamoxifen vs nil for patients with operable breast cancer
Phase:
N/A
Details
Lead Sponsor:
King Faisal Specialist Hospital & Research Center
Treatments:
Tamoxifen